| Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals. | |
| | |
MedLine Citation:
|
PMID: 21949623 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Rigid control of blood pressure (BP) is essential to prevent cardiovascular disease. However, only about 40% of hypertensive patients undergoing pharmacological intervention with a single agent achieve their BP goals in contemporary clinical practice. Combined therapy using currently available agents is effective in maximizing treatment outcome, although it raises medical costs and decreases the drug compliance rate. To overcome such negative consequences, a combination tablet containing an angiotensin II receptor blocker (ARB) with a small dose of hydrochlorothiazide (HCTZ) is now available on the international market, including Japan. This article briefly describes the unique properties of telmisartan, a highly selective ARB for the angiotensin II type 1 receptor, including its long-acting characteristics and recent prospective multicenter randomized clinical trials, followed by a description of a newly-introduced combination tablet in Japan, which contains telmisartan and HCTZ. This article also reviews its safety and efficacy based on currently available evidence. Finally, evidence comparing telmisartan/HCTZ with other combination therapies is presented. |
| | |
Authors:
|
Satoshi Morimoto; Nobuyuki Takahashi; Tatsuyori Morita; Kazunori Someya; Nagaoki Toyoda; Toshiji Iwasaka |
Related Documents
:
|
21071283 - Skin vascular resistance in the standing position increases significantly after 7days o... 11696263 - Orthostatic hypotension, 2001. 17142523 - Higher self-reported physical activity is associated with lower systolic blood pressure... |
Publication Detail:
|
Type: Journal Article Date: 2010-06-03 |
Journal Detail:
|
Title: Integrated blood pressure control Volume: 3 ISSN: 1178-7104 ISO Abbreviation: Integr Blood Press Control Publication Date: 2010 |
Date Detail:
|
Created Date: 2011-09-28 Completed Date: 2011-11-10 Revised Date: 2012-05-07 |
Medline Journal Info:
|
Nlm Unique ID: 101562709 Medline TA: Integr Blood Press Control Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 73-9 Citation Subset: - |
Affiliation:
|
Second Department of Internal Medicine, Kansai Medical University 2-3-1, Shinmachi, Hirakata, Osaka 573-1191, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness.
Next Document: Impact of telmisartan in modifying vascular risk.